Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Biologics is estimated at US$377.6 Billion in 2023 and is projected to reach US$656.8 Billion by 2030, growing at a CAGR of 8.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Recombinant Therapeutic Proteins segment, which is expected to reach US$246.6 Billion by 2030 with a CAGR of a 8.8%. The Blood & Blood components segment is also set to grow at 7.5% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $116.2 Billion in 2023, and China, forecasted to grow at an impressive 7.6% CAGR to reach $111.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as AbbVie, Inc., Amgen, Inc., AstraZeneca PLC, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 293 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $377.6 Billion |
| Forecasted Market Value (USD) by 2030 | $656.8 Billion |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Biologics - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
FOCUS ON SELECT PLAYERS(Total 243 Featured):
- AbbVie, Inc.
- Amgen, Inc.
- AstraZeneca PLC
- Bristol-Myers Squibb Company
- Celgene Corporation
- Eli Lilly and Company
- GlaxoSmithKline PLC
- Janssen Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Novartis AG
- Novo Nordisk A/S
- Pfizer, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/aojvci
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
